Browse the latest research summaries in the field of regenerative medicine for spinal cord injury patients and caregivers.
Showing 1,001-1,010 of 2,298 results
PLoS ONE, 2022 • January 27, 2022
This study investigates the potential of hair-follicle-associated pluripotent (HAP) stem cells to regenerate chronic spinal cord injury (SCI) in a mouse model. HAP stem cells, encapsulated in polyviny...
KEY FINDING: HAP stem cells implanted into the severed spinal cord differentiated into neurons, astrocytes, and oligodendrocytes in both C57BL/6J and nude mice.
eBioMedicine, 2022 • February 1, 2022
This study investigates the therapeutic efficacy of combining ultra-purified human bone marrow mesenchymal stem cells (RECs) and a bioresorbable gel for IVD regeneration after discectomy in a sheep mo...
KEY FINDING: Co-culturing RECs and nucleus pulposus cells (NPCs) in the gel significantly increased gene expression of NPC markers, growth factors, and extracellular matrix compared to monocultures.
npj Regenerative Medicine, 2022 • January 1, 2022
This review summarizes the role of the Hippo pathway in zebrafish regeneration, noting that Yap1/Taz signaling often enhances regeneration through promoting cell proliferation, progenitor cell dediffer...
KEY FINDING: Hippo pathway effectors Yap/Taz facilitate zebrafish regeneration, suggesting therapeutic potential in promoting YAP/TAZ signaling to enhance mammalian regeneration.
The Journal of Neuroscience, 2022 • March 16, 2022
This study aimed to identify novel axon growth activators induced in the adult CNS environment in vivo, focusing on Inpp5k's role in enhancing corticospinal tract (CST) axon growth after CNS trauma. T...
KEY FINDING: Inpp5k increases axon outgrowth of cortical neurons in vitro by increasing the availability of active nonphosphorylated cofilin within labile axonal growth cones.
Journal of Neuroinflammation, 2022 • January 26, 2022
This study investigates the potential of Maresin 1 (MaR1), an anti-inflammatory and proresolving mediator, to promote nerve regeneration and alleviate neuropathic pain after nerve injury, comparing it...
KEY FINDING: MaR1 demonstrated a more robust ability to promote sensory and motor function recovery in mice after sciatic nerve crush injury than NGF.
Journal of Inflammation Research, 2022 • January 26, 2022
This review highlights the critical role of inflammation in secondary spinal cord injury (SCI) and the potential of mesenchymal stem cells (MSCs) to modulate this inflammation. MSCs exert immunomodula...
KEY FINDING: MSCs can regulate macrophage polarization, shifting the balance from pro-inflammatory M1 to anti-inflammatory M2 phenotypes, which promotes axonal regeneration and reduces glial scar formation.
Protein Cell, 2022 • August 1, 2022
This study reveals that the BMP signaling pathway is deficient in the chemically defined 2i condition (N/2i), which greatly impairs the developmental potential of mESCs. Addition of BMP4 in N/2i conditi...
KEY FINDING: BMP4 activation can preserve the developmental potential and safeguard the chromosomal integrity of mESCs.
Journal of Immunology Research, 2022 • February 3, 2022
This study investigates the potential of ADSC-Exos as a cell-free therapeutic strategy for immune-mediated alopecia by examining their effects on hair growth both in vitro and in vivo. The results dem...
KEY FINDING: ADSC-Exos significantly promoted DPC proliferation and migration while also reducing apoptosis in vitro.
The Journal of Neuroscience, 2022 • April 13, 2022
This study investigates the role of CSPG/LAR/PTPr signaling in limiting neurogenesis and synaptic integration of transplanted human neural precursor cells (NPCs) in a rat model of spinal cord injury (...
KEY FINDING: CSPGs inhibit neurogenesis and synaptogenesis of human drNPC-O2 through activation of LAR and PTPr receptors in vitro.
ACS Chem Neurosci, 2022 • March 2, 2022
This study introduces novel small molecules, HJ-01 and HJ-02, designed to promote nerve regeneration through CSPG-containing scars by targeting PTPσ. These compounds restore nerve growth in vitro at n...
KEY FINDING: HJ-01 and HJ-02 restore sympathetic axon outgrowth over inhibitory CSPGs in a dose-dependent manner.